Antimutagenicity of phenothiazine-metal co-ordination complexes in chemically induced mutagenesis

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 381-385

  Tanaka, Masaru ^a   Molnár, Joseph ^a   Kidd, Sue ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Antimutagenicity; Metal complex and chemical mutagenesis; Phenothiazines

Indexed keywords

4 NITRO 1,2 PHENYLENEDIAMINE; ANTIMUTAGENIC AGENT; BACTERIAL DNA; CHLORPROMAZINE; COPPER; GOLD; PALLADIUM; PHENOTHIAZINE; PHENOTHIAZINE DERIVATIVE; PROMAZINE; PROMETHAZINE;

ARTICLE; BASE PAIRING; CONTROLLED STUDY; DNA ADDUCT; DRUG DNA INTERACTION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTICARCINOGENIC AGENTS; ANTIMUTAGENIC AGENTS; METALS; PHENOTHIAZINES;

EID: 0031042908     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jacob LS: Pharmacology, 2nd, Wiley Medical Publication. Pennsyvenia, 1987.
2. Molnar J, Beladi I, Feldes I: Studies on antituberculotic action of some phenothiazine derivatives in vitro. Zentralbl Bakteriol Orig A 259:521-526, 1977.
3. Molnar J, Foldeak S, Nakamura MJ, Rausch H, Domokos K, Szabo M: Antiplasmid activity: loss of bacterial resistance to antibiotics. APMIS Suppl 30: 24-31, 1992.
4. Molnar J, Galfi M, Lozsa A, Nakamura MJ: Inhibition of bacterial plasmid replication by stereoselective binding by tricyclic psychopharmacons. Res Commun Chem Pathol Pharmacol 43: 235-249, 1984.
5. Molnar J, Mandi Y, Holland IB, Schneider G: Antibacterial effect, plasmid curing activity and chemical structure of some tricyclic compounds. Acta Microbiol Acad Sci Hung 24: 1-6, 1977.
6. Molnar J, Mandi Y, Kiraly J: Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung 23: 45-54, 1976.
7. Molnar J, Mandi Y, Regely K, Tarnoky K, Nakamura MJ: Inhibition of biological effects of endotoxins by phenothiazines. In Vivo 6: 205-209, 1992.
8. Motohashi N, Sakagami H, Kurihara T, Csuri K, Molnar J: Antiplasmid activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res 12: 135-139, 1992.
9. Motohashi N, Sakagami H, Kurihara T, Ferenczy L, Csuri K, Molnar J: Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res 12: 1207-1210, 1992.
10. Takahara P, Rosenzweig AC, Frederich CA, Lippard SJ: Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377: 649-652, 1995.
11. Yang D, van Boom SSGE, Reedijik J, van Boom JH, Farrell N, Wang AHJ: A novel DNA structure induced by the anticancer bisplatinum compound crosslinked to pGpC site in DNA. Nature Struct Biol 2: 577-585, 1995.
12. Rice JA, Crothers DM, Pinto AL, Lippard SJ: The major adduct of the antitumor drug as-diaminedichloroplatinum (II) with DNA bends the duplex by > 40° toward the major groove. Proc Natl Acad Sci USA 85: 4158-4161, 1988.
13. Mellish KJ, Barnard CFJ, Murrer BA, Kelland L: DNA-binding properties of novel cis-and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines. Int J Cancer 62: 717-723, 1995.
14. Kada T, Inoue T, Ohta T, Shirasu Y, in Shankel, DM, Hartman PE, Kada T, Hollaender A (Eds.): Antimutagenesis and Anticarcinogenesis Mechanisms. Plenum, NewYork, pp. 181-196, 1986.
15. Waters MD, Brady AL, Stack HF, Brockman HE: Antimutagenicity profiles for some model compounds. Mutation Res 238: 57-85, 1990.
16. Kittle Jr JD, Calle LM, Sullivan PD: The effect of substituted phenothiazines on the mutagenicity of benzo[a]pyrene. Mutation Res 50:259-264, 1981.
17. Calle LM, Sullivan PD: Screening of antioxidants and other compounds for antimutagenic properties towards benzo[a]pyreneinduced mutagenicity in strain TA98 of Salmonella typhimurium. Mutation Res 101: 99-104, 1982.
18. 1 in vitro. Carcinogenesis 5: 1359-1362, 1984.
19. Maron DM, Ames BN: Revised methods for the Salmonella mutagenicity test. Mutation Res 113: 173-215, 1983.
20. Heller CS, Sevag MG: Prevention of the emergence of drug resistance in bacteria by acridines, phenothiazines and dibenzocycloheptenes. Appl Microbiol 14: 879-884, 1966.
21. Calle LM, Sullivan PD, Nettleman MD, Ocasio IJ, Blazyk J, Jollick J: Antioxidants and the mutagenicity of bezo[a]pyrene and some derivatives. Biochem Biophys Res Commun 85: 351-356, 1978.
22. Bichel MH: N-Oxide formation and related reactions in drug metabolism. Xenobiotica 1: 313-319, 1971.
23. Uehleke H: N-Hydroxylation. Xenobiotica 1: 327-338, 1971.
24. Sullivan PD, Calle LM, Ocasio IJ, Kettle Jr JD, Ellis LE: The effect of antioxidants on the mutagenicity of bezo[a]pyrene and derivatives. In: Bjorseth A, Dennis A.J. (Eds.) Polynuclear Aromatic Hydrocarbons: Chemistry and Biological Effects. Battelle, Columbus, pp. 163-175, 1980.
25. Omishi SI, McConnell HM: Interaction of the radical ion of chlorpromazine with deoxyribonucleic acid. J Am Chem Soc 87: 2293, 1965.
26. Jose JG: Photomutagenesis by chlorinated phenothiazine tranquilizers. Proc Natl Acd Sci USA 76: 469-472, 1979.
27. 1: In vitro effect of vitamins. Mutation Res 188: 121-128 1987.
28. Kada T, Kanematsu R: Reduction of N-methyl-N'-nitro-N-nitrosoguanidine induced mutations by cobalt chloride in Escherichia coli. Proc Jpn Acad 54: 234-237, 1987.
29. Nunoshiba T, Nishioka H: Sodium arsenite inhibits spontaneous and induced mutations in Eschehchia coli Mutation Res 184: 99-195, 1986.
30. Rosin MP, Sitch HF: Assessment of the use of the Salmonella mutagenesis assay to determine the influence of antioxidants on carcinogen-induced mutagenesis. Int J Cancer 23: 722-727, 1979.
31. Whiting RF, Wei L, Sitch HF: Mutagenic and antimutagenic activities of selenium compounds in mammalian cells. In: Spalholz JE, Martin JL, Ganther HE, Selenium in Biology and Medicine. AVI Publ Co Westport, pp. 325-330, 1981.
32. 1: In vitro effect of trace elements. Mutation Res 199: 85-93, 1988.
33. Prasanna P, Jacobs MM, Yang SK: Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100. Mutation Res 190: 101-105, 1987.
34. Teel RW, Kain SR: Selenium modified mutagenicity and metabolism of benzo[a]pyrene in an S9-dependent system. Mutation Res 127: 914, 1984.
35. Jacobs MM: Inhibitory effect of selenium on the mutagenicity of 2acetylaminofluorene and the AAF derivatives. Cancer Lett 2: 319-322, 1977.
36. Adams G, Martin S, Milner J: Effects of selenium on the Salmonella/microsome mutagen test system. Fed Proc 39: 790, 1980.
37. Griffin AC, Arnott MS, Vaneys J, Wang YM: (Eds.), Molecular Interrelations of Nutrition and Cancer. Rave, New York, pp. 401-408, 1982.
38. Ferguson LR: Antimutants as cancer chemopreventive agents in the diet. Mutation Res 307: 395-410, 1994.